COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION AND IMPROVING VACCINE PRODUCTION
Miltefosine is utilized to enhance immune response to vaccination, for example an influenza and/or coronavirus vaccination. The inventive subject matter also provides compositions and methods for enhancing viral yield in cultured cells, by application of a cannabinoid receptor agonist (such as methanandamide) to such cells. Such enhanced viral yield can be used to enhance virus production for purposes of vaccine formulation and/or to improve sensitivity of cell-based virus assays..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 19. Apr. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
YUEN KWOK YUNG [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-04-19, Last update posted on www.tib.eu: 2023-07-06, Last updated: 2023-07-14 |
---|
Patentnummer: |
EP3908315 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA014009587 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA014009587 | ||
003 | DE-627 | ||
005 | 20230714122033.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230215s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA014009587 | ||
035 | |a (EPA)EP3908315 | ||
035 | |a (EPA)71404059 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a YUEN KWOK YUNG |e verfasserin |4 aut | |
245 | 1 | 0 | |a COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION AND IMPROVING VACCINE PRODUCTION |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-04-19, Last update posted on www.tib.eu: 2023-07-06, Last updated: 2023-07-14 | ||
520 | |a Miltefosine is utilized to enhance immune response to vaccination, for example an influenza and/or coronavirus vaccination. The inventive subject matter also provides compositions and methods for enhancing viral yield in cultured cells, by application of a cannabinoid receptor agonist (such as methanandamide) to such cells. Such enhanced viral yield can be used to enhance virus production for purposes of vaccine formulation and/or to improve sensitivity of cell-based virus assays. | ||
650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) | |
650 | 4 | |a bio | |
650 | 4 | |a C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes | |
650 | 4 | |a tec | |
650 | 4 | |a 615 | |
700 | 0 | |a TO KAI WANG KELVIN |4 aut | |
700 | 0 | |a YUAN SHUOFENG |4 aut | |
700 | 0 | |a CHAN FUK WOO JASPER |4 aut | |
700 | 0 | |a ZHANG JINXIA |4 aut | |
700 | 0 | |a HUNG FAN NGAI |4 aut | |
700 | 0 | |a LAU JOHNSON YIU-NAM |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 19. Apr. |
773 | 1 | 8 | |g year:2023 |g day:19 |g month:04 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/71404059/publication/EP3908315A1?q=EP3908315 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 19 |c 04 |
951 | |a AR | ||
952 | |j 2023 |b 19 |c 04 |